Key Drivers Shaping the North America Anti-PD-1 mAb Market

a adăugat un sunet Health

2026-09-21 09:26:35 -

The Anti-PD-1 MAb Market in North America is witnessing steady growth as immune checkpoint inhibitors gain increasing adoption in cancer treatment. Anti-PD-1 monoclonal antibodies (MAbs) block the programmed cell death protein 1 (PD-1) pathway, helping enhance T-cell activity against cancer cells. Market Overview The anti-PD-1 mAb market stood at US$ 75.85 Million in 2025 and is forecast to...

0 Commentarii 0 Distribuiri 3 Views 0 previzualizare